Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001209191-20-049620

Chief Medical Officer sold 10,000 shares at $50.89 ($508,900)

  • Chief Medical Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Yu K Peony · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-09-03 Exercise or conversion : show line 1 in the form +10,000 $18.00 $180,000 215,576 D
2020-09-03 Sale : show line 2 in the form −10,000 $50.89 $508,900 205,576 D
Open-market sales · 10,000 sh · avg $50.89 · $508,900

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-09-03 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −10,000 $18.00 2024-11-13 10,000 42,500 D
Loading xslF345X03/doc4.xml…